about
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptorsHeteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.The Association Between Genetic Variants in the Dopaminergic System and Posttraumatic Stress Disorder: A Meta-AnalysisEvidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in miceSpeeded processing of grammar and tool knowledge in Tourette's syndromeEffect of apomorphine on cognitive performance and sensorimotor gating in humansDopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary studyA series of 18F-labelled pyridinylphenyl amides as subtype-selective radioligands for the dopamine D3 receptor.Dopamine receptor D2 is correlated with gastric cancer prognosis.Behavioral and Neural Manifestations of Reward Memory in Carriers of Low-Expressing versus High-Expressing Genetic Variants of the Dopamine D2 Receptor.Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients.Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent.Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust.The role of dopamine for the pathophysiology of schizophrenia.Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.Multimodal brain connectivity analysis in unmedicated late-life depression.Reward circuitry function in autism spectrum disordersLoss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting.Ligand-specific roles for transmembrane 5 serine residues in the binding and efficacy of dopamine D(1) receptor catechol agonistsSensitive determination of norepinephrine, epinephrine, dopamine and 5-hydroxytryptamine by coupling HPLC with [Ag(HIO6 )2 ](5-) -luminol chemiluminescence detection.A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence.GSK-3β activity and hyperdopamine-dependent behaviorsNeurobiological correlates of delusion: beyond the salience attribution hypothesis.A synergistic approach towards understanding the functional significance of dopamine receptor interactions.Drug-target residence time--a case for G protein-coupled receptors.Orquestic regulation of neurotransmitters on reward-seeking behavior.Advantageous sensitivity in the DNA homolog of the RNA dopamine aptamer.Aptamer and its applications in neurodegenerative diseases.Activation in the VTA and nucleus accumbens increases in anticipation of both gains and losses.Two-photon optical interrogation of individual dendritic spines with caged dopamine.Homeostatic mechanisms in dopamine synthesis and release: a mathematical model.Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome.The presence of comorbidity in Tourette syndrome increases the need for pharmacological treatment.Depression and social phobia secondary to alcohol dependence.Alcohol consumption is associated with an interaction between DRD2 exon 8 A/A genotype and self-directedness in males.Pavlovian-to-instrumental transfer effects in the nucleus accumbens relate to relapse in alcohol dependence.Top-down-directed synchrony from medial frontal cortex to nucleus accumbens during reward anticipation.Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects.
P2860
Q24630429-78EECA06-7C8F-4881-8BA2-E873469D4722Q24630645-7EA5C625-F0C4-4AE1-9E32-835AF66298ECQ26764813-656BA693-687C-4397-93F9-A1BB83D76399Q28296440-F07B17DE-6979-4F51-AC16-38DA54141907Q28757153-8D516FCE-22EE-44C1-8929-249948BFB205Q30484813-2F119279-4FF8-4CF3-9D44-0D31FEC297C7Q33530569-8B222E9B-5DC6-439D-A160-C795BC01E036Q33560926-1D1887A8-A5EE-4DCE-9839-CC0411C9758DQ33599147-F8281927-7BB1-4489-BB5C-56DF6A168554Q33619368-61B2D52A-2AAF-4F04-9E10-D366022BF381Q33647507-169FE27E-FB99-4D29-8F6A-366023EDF8EFQ34410506-474A5E48-59E2-44C3-B1B3-AE4813ACBEB9Q34574309-15096DA1-6B7A-4178-8F1B-6DA1CCD93240Q34658860-A8483E64-F67B-40EC-A215-4BAF894435EEQ34983219-071308C9-674B-476D-877F-121BA4354C7DQ34984566-488FBB5C-ADC7-4E90-A957-446948421BA4Q35157110-F5AF93CA-22DC-495F-8F7E-E44BA9301A28Q35750384-5BA9AEB1-E7C9-4585-9047-EFDFCE006C01Q35808940-A98D1281-84CB-452C-8437-4BC38B09EE91Q35882042-B9F85CCC-8B7E-4D4E-B031-088B94E4BF4DQ35913125-E21EB3B4-3F62-49F3-A751-CC5F7D4264C5Q35923696-11775E89-F6D5-4EBA-B83F-78564035E888Q36605165-2915D4E9-6BEB-4272-A532-1E4110B7EE5EQ37781424-DC9ACCB8-4CA1-4D55-877B-F21FA9FA8D36Q38026435-9ECCBC74-3361-4EF6-8686-04144FC62CCDQ38168871-642E223C-EADF-4BD1-AAB5-1600C3B23B2BQ38189272-D3EEDD9B-512F-497D-AA43-2FC5D38D8C62Q38233865-FE376AA4-FC4B-4889-A0B9-708EC57870A6Q38312356-03A3A0CB-B799-411E-8289-9DA893F9B86CQ38937721-638F5F90-F938-4D0F-8E4A-34454FF6FB31Q42113406-503FCB5F-52F3-4A00-AF4B-4268445B5F7DQ42564039-8E56FC37-1F1C-4F2E-A8FE-FF83823C9F10Q42574775-5D64E65F-30F6-406E-B91D-667BF4451F27Q43612123-4256CC29-7C27-43C6-9E0E-A2DBB500B512Q45983820-5F5C2D28-46F6-449F-A250-72637D5EFEDEQ46817091-166DA0C1-A963-4061-8E43-47A4C5B05FEAQ46945086-A66BD793-5456-43D7-BDA8-531874EF8E3DQ47664149-D8803F0E-4099-47ED-97DE-77164AC1E001Q48137874-AD4DD91E-3985-463D-B1F4-9198562F5162Q48174691-9F38EB1E-4EEF-4206-A27A-30A13FCC6F4F
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dopamine and the diseased brain.
@ast
Dopamine and the diseased brain.
@en
Dopamine and the diseased brain.
@nl
type
label
Dopamine and the diseased brain.
@ast
Dopamine and the diseased brain.
@en
Dopamine and the diseased brain.
@nl
prefLabel
Dopamine and the diseased brain.
@ast
Dopamine and the diseased brain.
@en
Dopamine and the diseased brain.
@nl
P1476
Dopamine and the diseased brain.
@en
P2093
P304
P356
10.2174/187152706784111560
P577
2006-02-01T00:00:00Z